Earnings watch · INCY · Healthcare

Incyte Corporation (INCY) enters July 28 report with weekly uptrend intact

The setup matters because recent biotechnology strength is being weighed against lighter weekly trading activity.

Incyte Corporation
Latest117.67 USD
1W move0.4%
Volume0.8x
TrendActive
Biotechnology lab and market data screens representing Incyte earnings watch.

Market update

What happened

Incyte Corporation (INCY) closed the latest week at $117.67 before its scheduled July 28 earnings release, with the earnings calendar pointing to a $1.61 estimate for the quarter ended June 30.

Weekly context is constructive but mixed. The 52-week weekly price path shows a stronger recent stretch, the trend signal remains active and Relative Strength is positive, while volume is running below its 13-week average and Market Dynamics shows only mild pressure.

Continue your research

Explore INCY across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

INCY coverage

Evidence context